SE304513B - - Google Patents

Info

Publication number
SE304513B
SE304513B SE27767A SE27767A SE304513B SE 304513 B SE304513 B SE 304513B SE 27767 A SE27767 A SE 27767A SE 27767 A SE27767 A SE 27767A SE 304513 B SE304513 B SE 304513B
Authority
SE
Sweden
Application number
SE27767A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE304513B publication Critical patent/SE304513B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE27767A 1963-12-06 1967-01-09 SE304513B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE304513B true SE304513B (de) 1968-09-30

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
SE27667A SE303507B (de) 1963-12-06 1967-01-09
SE27767A SE304513B (de) 1963-12-06 1967-01-09

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
SE27667A SE303507B (de) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (de)
AT (2) AT249054B (de)
BE (1) BE656759A (de)
CH (1) CH427803A (de)
DE (1) DE1445848A1 (de)
DK (4) DK108169C (de)
ES (5) ES306820A1 (de)
FR (2) FR1427775A (de)
GB (1) GB1034939A (de)
IL (1) IL22568A (de)
NL (1) NL6414138A (de)
SE (3) SE301652B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (de) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
JP2004514699A (ja) 2000-11-30 2004-05-20 ファイザー・プロダクツ・インク Gabaアゴニストおよびソルビトールデヒドロゲナーゼ阻害剤の組合せ
SK6092003A3 (en) 2000-11-30 2004-07-07 Pfizer Prod Inc Combination of GABA agonists and aldosereductase inhibitors
JP2006528676A (ja) * 2003-05-16 2006-12-21 ファイザー・プロダクツ・インク 非定形型抗精神病薬と、gaba調節薬及び/又は抗痙攣薬の治療上の組合せ
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
CA2553291A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
EP2377530A3 (de) 2005-10-21 2012-06-20 Braincells, Inc. Modulation von Neurogenese durch PDE-Hemmung
EP1942879A1 (de) * 2005-10-31 2008-07-16 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
MX2008014320A (es) * 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
BRPI0716604A2 (pt) * 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
ES306816A1 (es) 1965-05-16
ES306817A1 (es) 1965-05-16
AT250348B (de) 1966-11-10
SE301652B (de) 1968-06-17
NL6414138A (de) 1965-06-07
DK108169C (da) 1967-10-02
IL22568A (en) 1968-04-25
SE303507B (de) 1968-09-02
CH427803A (de) 1967-01-15
DE1445848A1 (de) 1968-11-21
ES306818A1 (es) 1965-05-16
DK106796C (da) 1967-03-20
FR1427775A (fr) 1966-02-11
FR4139M (de) 1966-05-02
DK106797C (da) 1967-03-20
AT249054B (de) 1966-09-26
ES306819A1 (es) 1965-05-16
US3242190A (en) 1966-03-22
GB1034939A (en) 1966-07-06
BE656759A (de) 1965-06-08
ES306820A1 (es) 1965-05-16
DK106733C (da) 1967-03-13

Similar Documents

Publication Publication Date Title
BE641143A (de)
FR4139M (de)
BE627012A (de)
BE629552A (de)
BE645790A (de)
BE645676A (de)
BE645116A (de)
BE645034A (de)
BE644956A (de)
BE644758A (de)
BE644431A (de)
BE644291A (de)
BE643337A (de)
BE642986A (de)
BE642909A (de)
BE642213A (de)
BE642046A (de)
BE635634A (de)
BE629549A (de)
BE627172A (de)
BE627151A (de)
BE627145A (de)
BE627141A (de)
BE627083A (de)
BE627025A (de)